Time Is Still The Enemy, Says Mom Who Moved Mountains For Her Epileptic Daughter & Still Advocates For Millions Of CBD Users
Portfolio Pulse from Nina Zdinjak
Paige Figi, mother of Charlotte Figi who inspired the FDA-approved CBD medicine Epidiolex by Jazz Pharmaceuticals (NASDAQ:JAZZ), advocates for CBD access and regulation through her non-profit, Coalition for Access Now. Despite CBD's legalization under the 2018 Farm Act, the market remains unregulated, posing safety risks. Figi supports bills H.R. 1629 and S. 2451 to regulate CBD as a dietary supplement, emphasizing the urgency due to the wide-ranging benefits of CBD for various consumer groups.
March 12, 2024 | 5:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jazz Pharmaceuticals' Epidiolex, inspired by Charlotte Figi's story, was the first FDA-approved CBD medicine for seizures. Paige Figi's advocacy for CBD regulation could influence the market and regulatory landscape for CBD products, including Epidiolex.
The story of Charlotte Figi and the subsequent approval of Epidiolex by Jazz Pharmaceuticals highlights the therapeutic potential of CBD. Paige Figi's continued advocacy for CBD regulation and access could positively impact the regulatory environment, potentially increasing the demand for regulated CBD products like Epidiolex. This advocacy could lead to a more favorable market and regulatory conditions for Jazz Pharmaceuticals.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80